US FDA pilot aims for 30-day review of 510(k)s submissions for IVDs, radiology devices

The US Food and Drug Administration has launched a six-month pilot programme under which it will aim to issue decisions on certain "good quality" pre-market notification (510(k)) submissions within 30 days, rather than its current standard of 90 days1.